GlassScriptPhysician profile
William Abe Segal
NPI 1275698516
$8,210.42
in general payments reported to CMS, 2019-2025
31 companies · $1,622 in 2025
The $1,622 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,299 · 2020: $683 · 2021: $1,403 · 2022: $1,067 · 2023: $1,055 · 2024: $1,082 · 2025: $1,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,654 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,653.54 |
| Education | $105.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,777.64 | 2019-2025 | Clareon, Ora System Verifeye, Clareon Panoptix Pro |
| Sun Pharmaceutical Industries INC. | $1,401.15 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $465.25 | 2022-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $427.54 | 2021-2025 | Acthar |
| Allergan, INC. | $328.20 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $240.28 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $232.64 | 2024-2025 | Amo Phaco Needle, Tecnis Simplicity, Tecnis Iol |
| Kala Pharmaceuticals, INC. | $224.92 | 2019-2022 | |
| Dompe US, INC. | $209.35 | 2020-2025 | Oxervate |
| Biotissue Holdings INC. | $203.46 | 2020-2023 | |
| Lensar, INC. | $162.64 | 2025 | Lensar Laser System |
| Rxsight INC | $157.61 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Glaukos Corporation | $145.92 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.01 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $102.48 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $97.04 | 2021 | |
| Iridex Corporation | $96.64 | 2021 | |
| Amgen INC. | $93.08 | 2025 | Tepezza |
| Harrow Eye, LLC | $90.45 | 2024 | Vevye |
| Sight Sciences, INC. | $85.35 | 2020-2023 | Tearcare System |
| Akorn, INC. | $85.33 | 2019 | |
| Merz Pharmaceuticals, LLC | $84.34 | 2021-2025 | Xeomin |
| Tarsus Pharmaceuticals, INC. | $84.03 | 2024-2025 | Xdemvy |
| Abbvie INC. | $59.83 | 2024-2025 | |
| Thea Pharma INC. | $58.18 | 2023 | Iyuzeh |
| Shire North American Group INC | $53.89 | 2019 | |
| Rayner Intraocular Lenses Limited | $40.73 | 2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Eyevance Pharmaceuticals LLC | $37.54 | 2019-2021 | |
| Astellas Pharma US INC | $26.55 | 2024 | Izervay |
| Carl Zeiss Meditec USA, INC. | $16.43 | 2025 | Cirrus Hd-Oct |
| Celgene Corporation | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Segal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.